A study to look for the usefulness of BAL test in blood cancer patients with pneumonia.
Not Applicable
- Registration Number
- CTRI/2018/10/016073
- Lead Sponsor
- Tata Memorial Centre Research Administrative Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients aged more than or equal to 15years
Leukemia and lymphomas on chemotherapy
Febrile neutropenia
Lung infiltrates on chest x-ray or CT chest
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of patients with a confirmed microbiological diagnosis using staged BAL analysisTimepoint: 24 hour
- Secondary Outcome Measures
Name Time Method a) The proportion of patients who have a change in antimicrobial therapy. <br/ ><br>b) The feasibility of doing a Bronchoscopy. <br/ ><br>c) The proportion of patients who develop major or minor complications during the procedure. <br/ ><br>d) The 4 and 12week clinical and radiological outcomes. <br/ ><br>e) The 30-day mortality rates. <br/ ><br>f) Correlation between radiological and etiological findings. <br/ ><br> <br/ ><br>Timepoint: 1)4th week <br/ ><br>2)30th Day <br/ ><br>3)12th week